BlackRock Institutional Trust’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,692,274
Closed -$96.3M 3965
2014
Q4
$96.3M Sell
2,692,274
-67,721
-2% -$2.02M 0.02% 899
2014
Q3
$71.8M Buy
2,759,995
+17,546
+0.6% +$504K 0.01% 1040
2014
Q2
$90.6M Buy
2,742,449
+5,978
+0.2% +$173K 0.02% 950
2014
Q1
$81.9M Buy
2,736,471
+74,402
+3% +$2.56M 0.01% 993
2013
Q4
$80.8M Buy
2,662,069
+26,066
+1% +$718K 0.01% 974
2013
Q3
$83.9M Sell
2,636,003
-60,135
-2% -$1.38M 0.02% 884
2013
Q2
$40.7M Buy
+2,696,138
New +$37.4M 0.01% 1277

Other funds holding NPSP

BlackRock Institutional Trust's NPSP Position: Q1 2015 in Review

BlackRock Institutional Trust sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 2,692,274 shares — an estimated $96.3M sold.

BlackRock Institutional Trust first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $96.3M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • BlackRock Institutional Trust reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BlackRock Institutional Trust sold 2,692,274 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $96.3M.
  • BlackRock Institutional Trust first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BlackRock Institutional Trust's NPS PHARMACEUTICALS INC position peaked at $96.3M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on BlackRock Institutional Trust's 13F filing for Q1 2015, filed 13 May 2015.